OneMedNet (ONMD) Stock Soars 90% on Platform Launch

Stock Jumps on Commercial Launch

OneMedNet Corporation (NASDAQ:ONMD) shares experienced a remarkable 90% surge following the announcement of the next commercial phase for its Real-World Data (RWD) Platform. This platform is notably powered by Palantir Foundry technology.

Platform Overview and Adoption

The company is transitioning customer evaluations into commercial, multi-year subscriptions, a move expected to generate millions in incremental recurring revenue. The platform offers access to multimodal datasets from over 2,130 healthcare sites, with adoption growing across the life sciences and AI health sectors.

Market and Company Impact

The significant stock price increase reflects strong investor confidence in OneMedNet's new recurring revenue model. According to CEO Aaron Green, positive customer feedback on the platform’s performance and analytical depth validates the company’s strategy of combining AI-driven search with scalable, prospective data feeds.

Summary and Outlook

The successful commercial launch solidifies OneMedNet's position in the RWD market. The company’s ability to secure long-term contracts will be a key factor for sustained growth as it continues to expand its subscription base and deliver value for real-world evidence generation.

FAQ

Q: Why did OneMedNet stock increase by 90%?
A: The stock surged after the company announced the commercial launch of its Real-World Data Platform and reported securing multi-year subscription deals.

Q: What does OneMedNet's platform do?
A: It provides life sciences and healthcare organizations with AI-driven access to regulatory-grade, real-world data from a network of over 2,130 healthcare sites.

Source: Investing.com